|

Hungarian National Systemic Amyloidosis Registry

RECRUITINGSponsored by Semmelweis University
Actively Recruiting
SponsorSemmelweis University
Started2026-03-08
Est. completion2028-05
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07689331

Summary

This registry is an observational, multicenter, retrospective and prospective, non-pharmacological study designed to collect and analyze data from patients with systemic amyloidosis treated in inpatient and outpatient cardiology, hematology, nephrology, and neurology departments across Hungary. The registry was established in 2025.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Diagnosis of systemic amyloidosis
* Patients aged ≥18 years at the time of enrollment
* Signed informed consent form by the patient
* Treating physician's consent
* Availability of accessible medical history

Exclusion Criteria:

* Lack of informed consent in the prospective study

Conditions5

AL AmyloidosisATTR AmyloidosisAmyloid CardiomyopathyCancerSystemic Amyloidosis

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.